Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
250 participants
INTERVENTIONAL
2020-10-05
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Screening for Breast Cancer-related Lymphedema
NCT01521741
Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema
NCT01599039
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
NCT03861975
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
NCT06580743
Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
NCT00282529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast cancer patients with lymphedema
Circumference tape measurements
centimeter and volume criterias
Indocyanine green lymphangiography
Presence of dermal backflow
bioimpedance spectroscopy
7.5 and 10 L-DEX criterias
Symptom score
using lymph-icf, DASH and SF-36 questionnaires
Breast cancer patients without lymphedema
Circumference tape measurements
centimeter and volume criterias
Indocyanine green lymphangiography
Presence of dermal backflow
bioimpedance spectroscopy
7.5 and 10 L-DEX criterias
Symptom score
using lymph-icf, DASH and SF-36 questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Circumference tape measurements
centimeter and volume criterias
Indocyanine green lymphangiography
Presence of dermal backflow
bioimpedance spectroscopy
7.5 and 10 L-DEX criterias
Symptom score
using lymph-icf, DASH and SF-36 questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No recurrence
* Understand the study
* Can talk, read and understand Danish
Exclusion Criteria
* Lymph node dissection from other basins
* Psychiatric disorder
* Not possible to perform indocyanine green lymphangiography
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mads Gustaf Jørgensen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Plastic and Reconstructive Surgery
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jens A Sørensen, MD, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-20200094
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.